ELVN |
Enliven Therapeutics, Inc. |
Aug 26, 2024 |
1 |
-$275K |
4 |
Aug 28, 2024 |
PRESIDENT AND CEO, Director |
ELVN |
Enliven Therapeutics, Inc. |
Jul 31, 2024 |
1 |
-$62.6K |
4 |
Aug 2, 2024 |
PRESIDENT AND CEO, Director |
ELVN |
Enliven Therapeutics, Inc. |
Jul 25, 2024 |
3 |
-$299K |
4 |
Jul 29, 2024 |
PRESIDENT AND CEO, Director |
ELVN |
Enliven Therapeutics, Inc. |
Jun 25, 2024 |
2 |
-$260K |
4 |
Jun 27, 2024 |
PRESIDENT AND CEO, Director |
ELVN |
Enliven Therapeutics, Inc. |
May 28, 2024 |
5 |
-$265K |
4 |
May 30, 2024 |
PRESIDENT AND CEO, Director |
ELVN |
Enliven Therapeutics, Inc. |
Apr 25, 2024 |
3 |
-$189K |
4 |
Apr 29, 2024 |
PRESIDENT AND CEO, Director |
ELVN |
Enliven Therapeutics, Inc. |
Apr 11, 2024 |
3 |
-$1.14M |
4 |
Apr 15, 2024 |
PRESIDENT AND CEO, Director |
ELVN |
Enliven Therapeutics, Inc. |
Mar 25, 2024 |
4 |
-$197K |
4 |
Mar 27, 2024 |
PRESIDENT AND CEO, Director |
ELVN |
Enliven Therapeutics, Inc. |
Feb 26, 2024 |
4 |
-$189K |
4 |
Feb 28, 2024 |
PRESIDENT AND CEO, Director |
ELVN |
Enliven Therapeutics, Inc. |
Feb 13, 2024 |
1 |
$0 |
4 |
Feb 15, 2024 |
PRESIDENT AND CEO, Director |
ELVN |
Enliven Therapeutics, Inc. |
Jan 25, 2024 |
4 |
-$175K |
4 |
Jan 29, 2024 |
President and CEO, Director |
ELVN |
Enliven Therapeutics, Inc. |
Dec 26, 2023 |
3 |
-$162K |
4 |
Dec 28, 2023 |
President and CEO, Director |
ELVN |
Enliven Therapeutics, Inc. |
Dec 21, 2023 |
6 |
-$97.7K |
4 |
Dec 26, 2023 |
President and CEO, Director |
ELVN |
Enliven Therapeutics, Inc. |
Dec 20, 2023 |
3 |
-$92.5K |
4 |
Dec 21, 2023 |
President and CEO, Director |
ELVN |
Enliven Therapeutics, Inc. |
Nov 3, 2023 |
3 |
-$96K |
4 |
Nov 6, 2023 |
President and CEO, Director |
ELVN |
Enliven Therapeutics, Inc. |
Sep 25, 2023 |
3 |
-$152K |
4 |
Sep 26, 2023 |
President and CEO, Director |
ELVN |
Enliven Therapeutics, Inc. |
Apr 4, 2023 |
1 |
$0 |
4 |
Apr 6, 2023 |
President and CEO, Director |
ELVN |
Enliven Therapeutics, Inc. |
Feb 23, 2023 |
5 |
$0 |
4 |
Feb 27, 2023 |
President and CEO, Director |
ELVN |
Enliven Therapeutics, Inc. |
Feb 23, 2023 |
0 |
$0 |
3 |
Feb 27, 2023 |
President and CEO, Director |
ELVN |
Enliven Therapeutics, Inc. |
Feb 23, 2023 |
0 |
$0 |
3 |
Feb 27, 2023 |
President and CEO, Director |